|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| (11) | Number of the document | 3531133 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18213926.1 |
| Date of filing the European patent application | 2015-05-20 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation | 2023-11-10 |
| (30) | Number | Date | Country code |
| 201462005560 P | 2014-05-30 | US |
| (72) |
Zugmaier, Gerhard , DE
Kufer, Peter , DE
Alekar, Shilpa , US
|
| (73) |
Amgen Research (Munich) GmbH ,
Staffelseestrasse 2, 81477 München,
DE
Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 91320-1799, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ūminės B pirmtakų limfoblastinės leukemijos pacientų rizikos stratifikacija |
| RISK-STRATIFICATION OF B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS |
| Payment date | Validity (years) | Amount | |
| 2024-04-18 | 10 | 231.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-10-23 |